Federated Hermes, Inc. 13D and 13G filings for Amphastar Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-06 10:23 am Sale |
2024-02-29 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
2,165,071 4.520% |
-1,107,690 (-33.85%) |
Filing |
| 2024-01-17 2:36 pm Sale |
2023-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
3,272,761 6.830% |
-11,456 (-0.35%) |
Filing |
| 2023-02-01 09:43 am Sale |
2022-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
3,284,217 6.800% |
-180,118 (-5.20%) |
Filing |
| 2022-02-14 1:29 pm Purchase |
2021-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
3,464,335 7.240% |
238,452 (+7.39%) |
Filing |
| 2022-02-14 1:21 pm Purchase |
2021-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
10,150,000 7.260% |
3,150,000 (+45.00%) |
Filing |
| 2021-02-12 3:01 pm Purchase |
2020-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
7,000,000 5.650% |
7,000,000 (New Position) |
Filing |
| 2021-02-12 2:55 pm Purchase |
2020-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
3,225,883 6.790% |
3,225,883 (New Position) |
Filing |